tirzepatide and cyclobenzaprine Nationwide Recalls for Cyclobenzaprine, Multiple Generics; Warnings for Briviact, Lupron Depot, Riluzole, Tepezza, Tiglutek; Pharma Ad Crackdown, More Not all GLP-1–based therapies Summer Flavor:Raspberry

tirzepatide and cyclobenzaprine Nationwide Recalls for Cyclobenzaprine, Multiple Generics; Warnings for Briviact, Lupron Depot, Riluzole, Tepezza, Tiglutek; Pharma Ad Crackdown, More Not all GLP-1–based therapies Summer Flavor:Raspberry

Not all GLP-1–based therapies work the same way. Semaglutide targets the GLP-1 receptor, while tirzepatide targets both GLP-1 and GIP receptors. Retatrutide is being studied as a triple-receptor agonist targeting GLP-1, GIP

Foundayo (Orforglipron): This once-daily oral medication, newly approved for GLP-1 weight loss management, offers flexibility with no food or water restrictions

Summer

Flavor:Raspberry

Lebrun et al., 2017